Efficacy of early transfusion of convalescent plasma with high-titer SARS-CoV-2 neutralizing antibodies in hospitalized patients with COVID-19.
Cristina SanzMeritxell NomdedeuArturo PereiraSilvia Sauleda OliverasRodrigo AlonsoMarta BesHelena BrillembourgCarolina García-VidalAnna MillanNuria Martínez-LlonchMaría PirónPedro Puerta-AlcaldeLluis PuigVeronica RicoAlex SorianoPublished in: Transfusion (2022)
Our results suggest that CCP can still be helpful in selected patients with COVID-19 and call for further studies before withdrawing CCP from the COVID-19 therapeutic armamentarium.